Nuno Pires

Background

About Nuno Pires

Passionate translational pharmacology lead with over 16 years’ experience in the pharmaceutical industry. Highly motivated to drive translational research of innovative therapies. Proactive, fast learner and accountable. Positive manager of the business needs in support of key programs milestones. Skilled across the drug development cycle. Strong expertise in disease biology, in vivo pharmacology and biomarkers to support discovery, development and progression of targeted therapies. Science lead on multiple assets in cardiovascular, neurology, neuropsychiatry and neurodegeneration indications. Strong contribution to Eslicarbazepine Acetate (Epilepsy) and Opicapone (Parkinson´s Disease) market entry and advancing Etamicastat (Hypertension and Congestive Heart Failure) and Zamicastat (Pulmonary Arterial Hypertension) to phase II clinical trials. Key responsibilities: • Work collaboratively with cross-functional research and clinical development teams for generation and implementation of novel biomarker strategies to advance asset development for multiple programmes and therapeutic areas. • Lead the generation of robust pharmacological and disease-relevant decisional data packages across diferent therapeutic areas. • Drive operational efficiency, including engagement with external experts and academic institutions. • Scientific assessment of business development opportunities and due diligence exercises. • Broad experience in Quality, including GLP. • Expert in managing, contracting, and monitoring in-life pharmacology and translational studies. • Development and review of regulatory documents.